CTRI/2014/11/005224招募中未知
ThromboemboliC DisOrders - A Registry oF Newly DIagnoseD PatiENts on Oral AntiCoagulation TrEatment (Vitamin K Antagonists): The CO(N)FIDENCE Registry - The Confidence Registry
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Patients of either sex aged between 18 and 80 years
- •2.Newly diagnosed patients prescribed with oral VKA alone or in combination with other antithrombotics (eg., Heparin, Aspirin, Clopidogrel) for:
- •i.Stroke prevention in atrial fibrillation (SPAF).
- •ii. Venous thromboembolism- VTE (DVT & PE).
- •iii. Valvular heart disease.
- •iv. Post prosthetic heart valve surgery.
- •3. Patients willing to sign the patient authorization form
排除标准
- •The patients with following condition/disorder will be excluded from the Registry:
- •1.Renal impairment.
- •2.Significant liver diseases (i.e. cirrhosis).
- •3.Active or high-risk bleeding.
- •4.Patients with anticipated non-adherence to VKA treatment; alcohol abuse; and allergic or intolerant to VKA.
- •5.Pregnant women or those planning to become pregnant.
研究者
相似试验
招募中
不适用
The National Dutch Stent Thrombosis Registryin-stent thrombosisblood clot in previously implanted coronary stent10011082NL-OMON47084Sint Antonius Ziekenhuis1,000
已完成
不适用
Prevention of Thromboembolic Events – European Registry in Venous ThromboembolismMedDRA - Venous ThromboembolismI82Other venous embolism and thrombosisDRKS00004795Daiichi-Sankyo Europe GmbH3,544
进行中(未招募)
1 期
Causes and prevention of thrombosis developed due to the kidney disease nephrotic syndromeephrotic syndrome is defined as severe proteinuria (> 0.5 g / day), edema and hypoalbuminemia. It is conditioned by a defect in the kidney's glomerular filtration barrier, resulting in the loss of a large number of plasma proteins including coagulation factors and consequently a increased risk of thromboembolic complications. The most frequent cause of nephrotic syndrome is the renal disease membranous nephropathy, which is associated with the greatest risk of thromboembolic complications.MedDRA version: 21.1Level: LLTClassification code 10029167Term: Nephrotic syndrome with lesion of membranous glomerulonephritisSystem Organ Class: 100000004857MedDRA version: 20.0Level: LLTClassification code 10029165Term: Nephrotic syndrome in diseases classified elsewhereSystem Organ Class: 100000004857EUCTR2019-001212-29-DKAarhus University Hospital, Henrik Birn70
招募中
不适用
Clinical and population characteristics of patients with primary Antiphospholipid syndrome (APS)RBR-9pm4r64Faculdade de Medicina da Universidade de São Paulo
已完成
不适用
Pathological investigation of thromboembolism in the obstetrics and gynecology disorderVenous ThromboembolismJPRN-UMIN000020759Department of Obstetrics and Gynecology, Kyushu University Hospital600
